Published in J Clin Microbiol on February 01, 1991
Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A (2010) 12.39
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 9.17
Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet (2009) 6.80
Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol (2004) 4.60
Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol (2008) 3.60
Vaginal self-swab specimen collection in a home-based survey of older women: methods and applications. J Gerontol B Psychol Sci Soc Sci (2009) 3.27
Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol (2007) 3.10
Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol (2008) 2.96
Potential uses of probiotics in clinical practice. Clin Microbiol Rev (2003) 2.80
Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One (2012) 2.79
Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol (2008) 2.73
Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol (2002) 2.67
Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis (2004) 2.67
Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One (2010) 2.62
Deep sequencing of the vaginal microbiota of women with HIV. PLoS One (2010) 2.59
The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis (2009) 2.56
Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect (2005) 2.55
From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev (2010) 2.42
The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG (2011) 2.41
Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol (2009) 2.29
Bacterial vaginosis. Clin Microbiol Rev (1991) 2.27
Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect (2002) 2.25
The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome (2014) 2.24
What is normal vaginal flora? Genitourin Med (1997) 2.22
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis (2008) 2.21
The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect (2011) 2.19
Baseline survey of sexually transmitted infections in a cohort of female bar workers in Mbeya Region, Tanzania. Sex Transm Infect (2003) 2.14
Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One (2011) 2.06
Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med (2012) 2.06
Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol (2007) 2.06
Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics (2010) 2.04
Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis (2010) 2.02
Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr (2010) 2.01
Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer (2006) 1.94
Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol (2010) 1.94
Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol (2012) 1.94
A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol (2007) 1.93
Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ (2004) 1.92
The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health (1998) 1.90
Evaluation of affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. J Clin Microbiol (1994) 1.89
Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol (2003) 1.89
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med (2011) 1.89
Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol (2010) 1.89
Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health (2001) 1.86
Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect (2008) 1.83
Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect (2010) 1.80
Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors. Bull World Health Organ (2007) 1.78
Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol (2000) 1.74
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.69
Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol (2010) 1.69
Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am J Obstet Gynecol (2011) 1.69
An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun (2004) 1.69
In vivo semen-associated pH neutralization of cervicovaginal secretions. Clin Diagn Lab Immunol (1997) 1.69
Dietary intake of selected nutrients affects bacterial vaginosis in women. J Nutr (2007) 1.68
Gardnerella vaginalis: characteristics, clinical considerations, and controversies. Clin Microbiol Rev (1992) 1.67
Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial. J Infect Dis (2010) 1.67
Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiol (2007) 1.66
Second trimester maternal plasma levels of cytokines IL-1Ra, Il-6 and IL-10 and preterm birth. J Perinatol (2012) 1.66
Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev (2007) 1.65
A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am J Epidemiol (2008) 1.63
Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr (2009) 1.61
Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol (2005) 1.60
Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis (2010) 1.59
The vaginal bacterial communities of Japanese women resemble those of women in other racial groups. FEMS Immunol Med Microbiol (2009) 1.59
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann Intern Med (2008) 1.59
Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J Clin Microbiol (2002) 1.59
From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis (2008) 1.58
Gram stain method shows better sensitivity than clinical criteria for detection of bacterial vaginosis in surveillance of pregnant, low-income women in a clinical setting. Infect Dis Obstet Gynecol (1998) 1.57
Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol (2005) 1.55
Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide. Sex Transm Infect (2000) 1.54
Pyrosequencing of the chaperonin-60 universal target as a tool for determining microbial community composition. Appl Environ Microbiol (2009) 1.53
Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women. BMC Infect Dis (2007) 1.51
Heterogeneity of vaginal microbial communities within individuals. J Clin Microbiol (2009) 1.50
Interpreting the epidemiology and natural history of bacterial vaginosis: are we still confused? Anaerobe (2011) 1.50
Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS One (2010) 1.47
Is Mycoplasma hominis a vaginal pathogen? Sex Transm Infect (2001) 1.46
Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease? Am J Obstet Gynecol (2008) 1.45
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest (2011) 1.44
Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One (2013) 1.43
Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect Dis Obstet Gynecol (2010) 1.43
The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One (2014) 1.43
Sexually transmitted infections among married women in Dhaka, Bangladesh: unexpected high prevalence of herpes simplex type 2 infection. Sex Transm Infect (2001) 1.39
Treating asymptomatic bacterial vaginosis in pregnancy. Can Fam Physician (2002) 1.39
The burden and determinants of reproductive tract infections in India: a population based study of women in Goa, India. Sex Transm Infect (2006) 1.38
The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Am J Obstet Gynecol (2008) 1.37
Validation data-based adjustments for outcome misclassification in logistic regression: an illustration. Epidemiology (2011) 1.35
Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol (2004) 1.35
A prospective cohort study of pregnancy risk factors and birth outcomes in Aboriginal women. CMAJ (2004) 1.35
Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc (2003) 1.30
Testing for sexually transmitted infections: a brave new world? Sex Transm Infect (2006) 1.30
Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect (2008) 1.30
Prevalence and abundance of uncultivated Megasphaera-like bacteria in the human vaginal environment. Appl Environ Microbiol (2008) 1.29
Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. PLoS One (2011) 1.28
Sexually transmitted and reproductive tract infections in symptomatic clients of pharmacies in Lima, Peru. Sex Transm Infect (2006) 1.28
Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health (2008) 1.28
Comparative study of vaginal Lactobacillus phages isolated from women in the United States and Turkey: prevalence, morphology, host range, and DNA homology. Clin Diagn Lab Immunol (2001) 1.28
Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome (2013) 1.28
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med (1983) 16.63
Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol (1955) 11.15
Misinterpretation and misuse of the kappa statistic. Am J Epidemiol (1987) 8.29
Anaerobic bacteria in nonspecific vaginitis. N Engl J Med (1980) 6.74
A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med (1988) 5.32
Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA (1986) 4.62
Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol (1983) 4.42
Selective differential human blood bilayer media for isolation of Gardnerella (Haemophilus) vaginalis. J Clin Microbiol (1982) 4.28
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol (1986) 3.67
Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol (1990) 3.28
Comparison of methods for diagnosing bacterial vaginosis among pregnant women. J Clin Microbiol (1989) 3.06
DIAGNOSIS OF HEMOPHILUS VAGINALIS VAGINITIS BY GRAM-STAINED SMEARS. Am J Obstet Gynecol (1965) 3.03
Proline aminopeptidase activity as a rapid diagnostic test to confirm bacterial vaginosis. Obstet Gynecol (1988) 2.75
Reproducibility of interpretation of Gram-stained vaginal smears for the diagnosis of bacterial vaginosis. J Clin Microbiol (1990) 2.22
Semiquantitative culture of Gardnerella vaginalis in laboratory determination of nonspecific vaginitis. J Clin Microbiol (1983) 1.90
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet (1997) 7.52
Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis (1999) 6.85
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (2000) 5.15
Improved detection times for Mycobacterium avium complex and Mycobacterium tuberculosis with the BACTEC radiometric system. J Clin Microbiol (1985) 4.58
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis (1999) 3.95
A review of premature birth and subclinical infection. Am J Obstet Gynecol (1992) 3.76
The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis (1993) 3.32
Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol (1990) 3.28
Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis (1996) 3.23
Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis (1991) 3.17
Comparison of methods for diagnosing bacterial vaginosis among pregnant women. J Clin Microbiol (1989) 3.06
Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis (2001) 2.86
Sexually transmitted diseases in victims of rape. N Engl J Med (1990) 2.74
The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol (1992) 2.32
Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1992) 2.27
Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med (2001) 2.23
The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol (1992) 2.15
The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol (1993) 2.12
Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1996) 2.10
Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol (1996) 2.07
Tetracycline resistance and tetM in pathogenic urogenital bacteria. Antimicrob Agents Chemother (1986) 2.01
Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis (2001) 1.96
Evaluation of affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. J Clin Microbiol (1994) 1.89
Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis (2000) 1.79
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev (2001) 1.77
Vaginal Bacteroides species are associated with an increased rate of preterm delivery among women in preterm labor. J Infect Dis (1991) 1.77
Nitrocellulose filter blots for species identification of Mobiluncus curtisii and Mobiluncus mulieris. J Clin Microbiol (1984) 1.75
Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J Infect Dis (1991) 1.68
Comparison of gram stain, DNA probe, and culture for the identification of species of Mobiluncus in female genital specimens. J Infect Dis (1985) 1.66
Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. J Infect Dis (1991) 1.62
Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J Clin Microbiol (1992) 1.61
Sialidase (neuraminidase) activity among gram-negative anaerobic and capnophilic bacteria. J Clin Microbiol (1990) 1.58
Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations. Antimicrob Agents Chemother (2007) 1.58
Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. Am J Obstet Gynecol (1993) 1.53
Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol (1990) 1.52
Vaginal indicators of amniotic fluid infection in preterm labor. Obstet Gynecol (2001) 1.50
Genetic basis of tetracycline resistance in urogenital bacteria. Antimicrob Agents Chemother (1990) 1.48
Broad-spectrum bacterial rDNA polymerase chain reaction assay for detecting amniotic fluid infection among women in premature labor. Clin Infect Dis (1997) 1.48
Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob Agents Chemother (2006) 1.47
The vaginal microflora of pig-tailed macaques and the effects of chlorhexidine and benzalkonium on this ecosystem. Sex Transm Dis (1997) 1.46
Microbiologic characteristics of Lactobacillus products used for colonization of the vagina. Obstet Gynecol (1990) 1.46
Optimization of media for detection of hydrogen peroxide production by Lactobacillus species. J Clin Microbiol (2003) 1.45
Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol (1991) 1.44
The risk of repeating low birth weight and the role of prenatal care. Obstet Gynecol (1994) 1.43
HIV infection and vaginal douching in central Africa. AIDS (1997) 1.42
Detection of Tet M and Tet O tetracycline resistance genes by polymerase chain reaction. Mol Cell Probes (1993) 1.41
Association of viridans group streptococci from pregnant women with bacterial vaginosis and upper genital tract infection. J Clin Microbiol (1988) 1.39
Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis (1999) 1.38
Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol (2000) 1.36
Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Am J Obstet Gynecol (1999) 1.34
Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1998) 1.32
Safety and efficacy evaluations for vaginal and rectal use of BufferGel in the macaque model. Sex Transm Dis (2004) 1.26
Barriers to screening sexually active adolescent women for chlamydia: a survey of primary care physicians. J Adolesc Health (2001) 1.25
Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol (2000) 1.25
Hemagglutination, adherence, and surface properties of vaginal Lactobacillus species. J Infect Dis (1995) 1.24
Vaginal colonization by Escherichia coli as a risk factor for very low birth weight delivery and other perinatal complications. J Infect Dis (1997) 1.23
Effects of nonoxynol-9 on vaginal microflora and chlamydial infection in a monkey model. Sex Transm Dis (1997) 1.23
The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group. J Infect Dis (1995) 1.22
Rapid presumptive identification of black-pigmented gram-negative anaerobic bacteria by using 4-methylumbelliferone derivatives. J Clin Microbiol (1991) 1.18
The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Infect Dis (1995) 1.18
Rapid diagnostic test that uses isocitrate lyase activity for identification of Yersinia pestis. J Clin Microbiol (1981) 1.18
C-reactive protein in normal pregnancy. Obstet Gynecol (1991) 1.14
Four methods of measuring human corneal endothelial cells from specular photomicrographs. Arch Ophthalmol (1980) 1.14
Race/ethnicity, vaginal flora patterns, and pH during pregnancy. Sex Transm Dis (1999) 1.12
Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J Infect Dis (2000) 1.10
Genital flora in pregnancy and its association with intrauterine growth retardation. J Clin Microbiol (1994) 1.09
The pig-tailed macaque rectal model: microflora and chlamydial infection. Sex Transm Dis (2001) 1.08
Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol (2005) 1.08
Reproducibility of a scoring system for gram stain diagnosis of bacterial vaginosis. J Clin Microbiol (1991) 1.06
Longitudinal study of the biotypes of Gardnerella vaginalis. J Clin Microbiol (1990) 1.04
The bacterial etiology of conjunctivitis in early infancy. Eye Prophylaxis Study Group. Am J Epidemiol (1993) 1.04
Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol (1995) 1.03
Amniotic fluid infection, cytokines, and adverse outcome among infants at 34 weeks' gestation or less. Obstet Gynecol (2001) 1.03
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole. J Antimicrob Chemother (1993) 1.02
Evaluation of the enhanced rapid identification method for Gardnerella vaginalis. J Clin Microbiol (1989) 1.02
Analysis of restriction fragment length polymorphisms of the insertion sequence IS1381 in group B Streptococci. J Infect Dis (2000) 1.01
Effect of transport time, temperature, and concentration on the survival of group B streptococci in amies transport medium. J Clin Microbiol (2004) 1.00
Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis. Sex Transm Infect (2007) 0.99
Diversity of surface protein expression in group B streptococcal colonizing & invasive isolates. Indian J Med Res (2004) 0.99
Amoxicillin treatment of bacterial vaginosis during pregnancy. Obstet Gynecol (1991) 0.99
Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis (1999) 0.98
Mucopurulent cervicitis as a predictor of chlamydial infection and adverse pregnancy outcome. The Investigators of the Johns Hopkins Study of Cervicitis and Adverse Pregnancy Outcome. Sex Transm Dis (1992) 0.98
Vaginal myeloperoxidase and flora in the pig-tailed macaque. J Med Primatol (2000) 0.97
Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med (2000) 0.97
Bacteria in the prostate tissue of men with idiopathic prostatic inflammation. J Urol (1997) 0.95
Automated perimetry: background, instruments and methods. Surv Ophthalmol (1978) 0.95
Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis (2001) 0.95